Skip to main content
Clinical Trials/ITMCTR2000003603
ITMCTR2000003603Not yet recruiting未知

Clinical research for the integrated traditional and western medicine in the treatment of triple negative breast cancer

onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 70 (—)
Sex
Female

Inclusion Criteria

  • (l) 18-70 years old;
  • (2) The results of immunohistochemistry showed that Er - / < 1% + and PR - / < 1% + and HER-2 (- / +) / fish had no amplification;
  • (3) TNM stage was ? ~ ?;
  • (4) 3 months after pathological diagnosis to the end of chemotherapy and radiotherapy;
  • (5) ECOG score was 0-1;
  • (6) There was no serious organic or functional disease;
  • (7) Willing to accept long-term TCM treatment, observation and various examinations.

Exclusion Criteria

  • (1) Recurrence and metastasis;
  • (2) The patients with recurrence and metastasis are to be excluded from clinical follow-up;
  • (3) Patients who can not take traditional Chinese medicine due to smell and other reasons;
  • (4) Women who are lactating, pregnant or preparing for pregnancy;
  • (5) Allergic constitution and allergic to many drugs;
  • (6) Patients with severe primary diseases of cardio cerebrovascular, liver, kidney and hematopoietic system and mental illness;
  • (7) Subjects who are participating in other drug trials;

Investigators

Sponsor
onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Similar Trials